Is There a Pill for Tinnitus? What the Drug Trials Found

The question arrives early and it deserves a direct answer: there is no medication approved anywhere for treating tinnitus. Not in the US, not in Europe. Every drug taken in connection with tinnitus is being used for something adjacent to it, or off-label on evidence that did not hold.

This article covers what was tried and what happened, because "there's no pill" is easier to accept when you can see the trials it came from.

One clarification first, because the vocabulary collides: this is about drugs tried against tinnitus. Drugs that cause or worsen it are a different list entirely, covered on the medications linked to tinnitus page and in the article on ototoxic medications.

What the guideline says

The American Academy of Otolaryngology–Head and Neck Surgery's clinical practice guideline on tinnitus makes a recommendation against antidepressants, anticonvulsants, anxiolytics and intratympanic medications for the routine treatment of persistent, bothersome tinnitus.

Four drug classes, one recommendation, all pointing the same way. That is the shortest summary of half a century of pharmacological effort on this symptom.

Anticonvulsants: the class with the most trials behind it

Anticonvulsants were a reasonable idea. If tinnitus involves hyperactive neural firing, a class of drugs that stabilises overactive neurons is exactly what you would try.

A Cochrane review pooled seven trials covering 453 patients, across gabapentin, carbamazepine, lamotrigine and flunarizine. The findings, in order of what matters:

• Three studies used a validated questionnaire as their primary outcome. None showed a significant positive effect.
• One of those studies found a significant negative effect: gabapentin raised Tinnitus Questionnaire scores by 18.4 points compared with placebo — the tinnitus got worse.
• Pooling the gabapentin data across studies produced no effect (SMD 0.07, 95% CI −0.26 to 0.40).
• A secondary analysis of "any positive effect" on a self-assessment score did find a small favourable difference (14%, 95% CI 6% to 22%). An analysis of "near or total eradication of tinnitus annoyance" found nothing (4%, 95% CI −2% to 11%).
• 18% of patients experienced side effects.

The reviewers' own conclusion is that the existing evidence carries significant risk of bias, that there is no evidence of a large positive effect, and that the small effect demonstrated is "of doubtful clinical significance".

Worth holding onto that split: the only positive signal came from asking people whether anything felt better, not from the validated instruments, and it disappeared entirely once the question became whether the tinnitus had substantially gone.

Lidocaine: the finding that goes nowhere

Intravenous lidocaine is the most interesting negative result in tinnitus pharmacology, because it is not actually negative — it just cannot be used.

In a study of 30 patients given lidocaine by intravenous infusion at 1.5 mg/kg over 30 minutes, four patients (13.3%) reported total suppression of their tinnitus immediately afterwards, and three more (10%) reported partial relief. The researchers also measured otoacoustic emissions before and after, finding statistically significant changes in cochlear responses.

So roughly a quarter of the group had their tinnitus measurably interrupted by a drug. And it is not a treatment, for reasons that are not going to be solved:

• It requires intravenous infusion, not a tablet.
• The suppression is temporary.
• Lidocaine is an antiarrhythmic with real cardiac effects, which makes repeated infusion for a non-life-threatening symptom impossible to justify.

Its value is the same as the value of residual inhibition: proof that the phantom signal can be switched off, and therefore that it is a signal rather than a permanent structural fact. Nobody has converted either finding into something you can take home.

Where a drug genuinely does have a role

None of the following is treating the tinnitus signal. All of them are worth knowing, because "no drug treats tinnitus" gets misread as "there is no point discussing medication with a doctor".

For co-occurring depression or anxiety. SSRIs are prescribed for the mood and anxiety that frequently accompany chronic tinnitus, and improving those can substantially change how much the tinnitus intrudes without altering the sound at all. That article also covers the other direction — tinnitus is listed as a possible side effect of nearly every SSRI.

For one specific syndrome. Typewriter tinnitus — a rare, staccato, one-sided presentation caused by a vessel compressing the auditory nerve — responds to carbamazepine in most reported patients. This is not an exception to the guideline; the guideline's subject is routine tinnitus, and this is a defined syndrome with an identified mechanism.

For an underlying condition. If the tinnitus is downstream of something treatable — an infection, a thyroid problem, anemia, high blood pressure — treating that is the intervention, and any tinnitus improvement follows from it.

Not for sleep, indefinitely. Benzodiazepines are sometimes prescribed for the sleeplessness that comes with new tinnitus. They work, and they carry dependence risk, and stopping them after long-term use has its own documented association with tinnitus during withdrawal. That is a genuinely difficult trade-off rather than a simple no.

Why nothing general has worked

The most likely reason is that "tinnitus" is not one condition. A phantom sound following blast exposure, one accompanying Ménière's disease, one driven by a jaw problem and one arriving with age-related hearing loss share a symptom and not a mechanism. A drug developed against any single mechanism is being tested, in most trials, on a population where most participants have a different one.

That is also why the current wave of drug development is narrower by design — targeting cochlear synaptopathy specifically, or shared neural hypersensitivity in people who also have migraine, rather than "tinnitus". Where that stands is covered in where tinnitus research is headed: candidates in early trials, none available, and most drugs at that stage never arriving.

What to actually do with this

• Do not go looking for a prescription for tinnitus itself. There is nothing to ask for, and the one class with the most trials behind it produced a trial where the tinnitus got measurably worse.
• Do raise mood, anxiety and sleep with a doctor, which are treatable, are frequently the part doing the real damage, and are where medication has a legitimate role.
• Do describe your tinnitus precisely. The narrow exceptions above are identified by pattern — staccato and one-sided, or episodic with vertigo and fullness — not by asking whether anything can be done.
• Do not wait for the drug you read about. The compounds developed specifically for tinnitus — AM-101, OTO-313 and the rest — have reported their controlled trials, and every one of them failed its primary endpoint. A press release outlives a result.
• Treat any product marketed as a tinnitus drug or supplement with the guideline in mind: ginkgo, melatonin and zinc are named in the same document, in the same direction. The supplements articles cover why.